“…Exclusion criteria were urinary retention, prostate carcinoma, acute or chronic prostatitis, urethral stricture, intravesical pathology (stones, neoplasm), neurogenic bladder dysfunction, urinary tract infection, isolated enlargement of the middle lobe, use of drugs influencing bladder or prostate function, disorders of blood flow or coagulation and diabetes mellitus. The TUMT treatment in general has been described before 12 . After treatment, patients were asked to remain in the department until satisfactory voiding had been established.…”